EP1242611A4 - Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein - Google Patents

Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein

Info

Publication number
EP1242611A4
EP1242611A4 EP00991434A EP00991434A EP1242611A4 EP 1242611 A4 EP1242611 A4 EP 1242611A4 EP 00991434 A EP00991434 A EP 00991434A EP 00991434 A EP00991434 A EP 00991434A EP 1242611 A4 EP1242611 A4 EP 1242611A4
Authority
EP
European Patent Office
Prior art keywords
compositions
staphylococcus aureus
encoded protein
methods involving
aureus gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00991434A
Other languages
German (de)
French (fr)
Other versions
EP1242611A2 (en
Inventor
Jerry Pelletier
Philippe Gros
Michael Dubow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Targanta Therapeutics Inc
Original Assignee
Targanta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/470,512 external-priority patent/US6376652B1/en
Priority claimed from US09/689,952 external-priority patent/US7101969B1/en
Application filed by Targanta Therapeutics Inc filed Critical Targanta Therapeutics Inc
Publication of EP1242611A2 publication Critical patent/EP1242611A2/en
Publication of EP1242611A4 publication Critical patent/EP1242611A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP00991434A 1999-12-22 2000-12-21 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein Withdrawn EP1242611A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/470,512 US6376652B1 (en) 1998-12-03 1999-12-22 Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
US470512 1999-12-22
US09/689,952 US7101969B1 (en) 1998-12-03 2000-10-12 Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
US689952 2000-10-12
PCT/US2000/035180 WO2001046383A2 (en) 1999-12-22 2000-12-21 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein

Publications (2)

Publication Number Publication Date
EP1242611A2 EP1242611A2 (en) 2002-09-25
EP1242611A4 true EP1242611A4 (en) 2004-08-11

Family

ID=27043114

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00991434A Withdrawn EP1242611A4 (en) 1999-12-22 2000-12-21 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein

Country Status (5)

Country Link
EP (1) EP1242611A4 (en)
JP (1) JP2003517833A (en)
AU (1) AU778782B2 (en)
CA (1) CA2396674C (en)
WO (1) WO2001046383A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004522945A (en) * 2000-12-01 2004-07-29 ファゲテック，インコーポレイティド Compositions and methods related to the Staphylococcus aureus essential gene and its encoded protein STAAU_R2

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032825A2 (en) * 1998-12-03 2000-06-08 Phagetech, Inc. Development of anti-microbial agents based on bacteriophage genomics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032825A2 (en) * 1998-12-03 2000-06-08 Phagetech, Inc. Development of anti-microbial agents based on bacteriophage genomics

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BRUAND C ET AL: "PRIMOSOME ASSEMBLY SITE IN BACILLUS SUBTILIS", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 14, no. 11, 1995, pages 2642 - 2650, XP001018848, ISSN: 0261-4189 *
DATABASE EBI [online] 1 January 1988 (1988-01-01), OGASAWARA, N. ET AL.: "Bacillus subtilis DnaI", XP002267921, Database accession no. P06567 *
DATABASE EBI [online] 1 October 2000 (2000-10-01), TAKAMI, H. ET AL.: "Bacillus halodurans DnaI", XP002267917, Database accession no. Q9K863 *
DATABASE EBI [online] 13 August 1997 (1997-08-13), OGASAWARA, N. ET AL.: "Bacillus subtilis dnaB gene for initiation of chromosomal replication", XP002267919, Database accession no. X04963 *
DATABASE EBI [online] 16 March 1999 (1999-03-16), KUNSCH CA ET AL.: "Staphylococcus aureus contig SEQ ID #106", XP002267918, Database accession no. AAV74417 *
DATABASE EBI [online] 19 March 1999 (1999-03-19), KUNSCH CA ET AL.: "Enterococcus faecalis genome contig SEQ ID NO:341", XP002267920, Database accession no. AAX13278 *
DATABASE EBI [online] 2 August 2000 (2000-08-02), KIMMERLY, W.J. ET AL.: "Staphylococcus epidermis strain SR1 clone step.1049g03 genomic sequence", XP002267915, Database accession no. AF270108 *
DATABASE EBI [online] 27 August 1998 (1998-08-27), BLACK MT ET AL.: "DNA encoding a Staphylococcus aureus protein of unknown function", XP002268024, Database accession no. AAT83989 *
DATABASE EBI [online] 7 August 2000 (2000-08-07), QIAN Y. ET AL.: "Staphylococcus aureus clone sabac-135, complete sequence", XP002267916, Database accession no. AC078832 *

Also Published As

Publication number Publication date
WO2001046383A3 (en) 2002-01-03
CA2396674C (en) 2006-07-04
WO2001046383A9 (en) 2002-07-11
AU3266201A (en) 2001-07-03
JP2003517833A (en) 2003-06-03
AU778782B2 (en) 2004-12-23
EP1242611A2 (en) 2002-09-25
CA2396674A1 (en) 2001-06-28
WO2001046383A2 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
AU1478301A (en) Staphylococcus epidermidis nucleic acids and proteins
AU5133099A (en) Pet toy
EP1165586A4 (en) TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
AUPQ419099A0 (en) Novel compositions and methods
AU2002357119A1 (en) Mitocidal compositions and methods
GB9920678D0 (en) Sanitising compositions and methods
EP1233974A4 (en) 37 staphylococcus aureus genes and polypeptides
AU2184099A (en) Insecticidal compositions and insecticidal methods
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
EP1461047A4 (en) Compositions and methods for animal treatment
EP1109911A4 (en) Staphylococcus aureus genes and polypeptides
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002226212A1 (en) Compositions and methods involving staphylococcus aureus protein STAAU-R9
AU2621202A (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau r9
EP1242611A4 (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein
AU2002346029A1 (en) Novel synergistic antimicrobial compositions and methods
GB0318113D0 (en) ›-Secretase enzyme compositions and methods
AU2042202A (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau r2
AU2469202A (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau r4
AU1477601A (en) Genetic compositions and methods
AU2002224692A1 (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein STAAU_R4
AU4808200A (en) Dna balls
AU2002359869A1 (en) Pak5-related compositions and methods
EP1071694A4 (en) Staphylococcus aureus spo0j2: polynucleotide and protein
AU2002319553A1 (en) Staphylococcus aureus proteins and nucleic acids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020722

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040628

17Q First examination report despatched

Effective date: 20040820

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TARGANTA THERAPEUTICS INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080206